fda warning compounded semaglutide π¨ Moves to Permanently Shut Down GLP-1s The FDA is taking steps to eliminate large-scale compounding of GLP-1 medications like and tirzepatide, signaling a major shift in how these FDA Warns of Dosing Errors
Description
Regular skin inspection is equally important

It does bring up a question, though: is it better to take them as a single compounded injection or as separate medications

Which supplements should you avoid on a GLP-1
The IAP cites FDA approval guidelines for liraglutide and semaglutide for children 12 years and older in children with class 3 obesity of life-threatening comorbidities who have a BMI greater or equal to 40

I feel healthier and more energetic
